Skip to main navigation
AC Immune - World-class science that makes a difference in  patients' lives
  • About Us
    About us Our Teams Our Partners Our R&D Strategy
  • Our Science
    Our Science Pioneering Precision Medicine Technology Platforms Scientific Publications
  • Our Pipeline
    Our Pipeline Therapeutic Focus Clinical Trials
  • Investors
  • Careers
    Careers Join us
Investors
  • Why Invest
  • Key Figures
  • Share Price
  • Analyst Coverage
  • Milestones
  • Key Shareholders
  • FAQ
  • Contacts & Resources
Press Releases
In the News
Events & Presentations
Corporate Governance
Financial Reporting
Annual Reports
search

Press Releases

  1. Home
  2. Investors
  3. Press Releases

PRESS RELEASES

 
Date Title View
Sep 05, 2023 AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
Aug 04, 2023 AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
Jul 28, 2023 AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023
Jul 26, 2023 AC Immune SA Appoints New Chief Medical Officer
Jul 03, 2023 AC Immune Showcasing Precision Medicine Programs at AAIC 2023
Jun 27, 2023 AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease
Jun 23, 2023 AC Immune Holds Annual General Meeting of Shareholders
Apr 28, 2023 AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update
Apr 05, 2023 AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s Disease
Mar 20, 2023 AC Immune at AD/PD™ 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline
  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »

Shareholder Tools

Print Page
Print Page
Email Alerts
Email Alerts
Information Request
Information Request
Contact IR
Contact IR

AC Immune SA

EPFL Innovation Park-Building B 1015 Lausanne / Switzerland
  • Phone: +41 21 345 91 21
  • Fax: +41 21 345 91 20
  • Email: info@acimmune.com
  • Home
  • About Us
  • Our Science
  • Our Pipeline
  • Investors
  • Careers

Stay in touch

Get to know us

Social Links (Redesign)

© 2023 AC Immune SA

Legal Links (Redesign)

  • Privacy policy
  • Supplier information
  • Terms of use